What changed between revision 1 and revision 3, compared over the article's markdown source with its frontmatter — so a change to status, evidence or reversibility shows up as the edit it is.
Older · revision 1
Import· initial corpus import, not an edit
Initial import of content/synthetic-embryos.md — the filesystem corpus, unchanged. Not an edit.
12.6 kB
Revision 1
Revision 3
lines 8–16 → 8–177 unchanged lines not shown
categories: ["reproduction", "genetics"]categories: ["reproduction", "genetics"]tags: ["embryo models", "stem cells", "developmental biology", "14-day rule", "bioethics", "regulation"]tags: ["embryo models", "stem cells", "developmental biology", "14-day rule", "bioethics", "regulation"]summary: "Structures grown by aggregating stem cells that reproduce stages of early embryonic development without fertilisation, and the regulatory categories they fall outside."summary: "Structures grown by aggregating stem cells that reproduce stages of early embryonic development without fertilisation, and the regulatory categories they fall outside."updated: "2026-07-27"updated: "2026-10-29"humanEvidence: "Nothing has been done in a person. Human work is confined to cultured cells, and no embryo model in any species has produced a live animal after transfer to a uterus."humanEvidence: "Nothing has been done in a person. Human work is confined to cultured cells, and no embryo model in any species has produced a live animal after transfer to a uterus."access: "Not a product and not for sale: the models are made in research laboratories from pluripotent stem cell lines, and none is offered clinically or reproductively."access: "Not a product and not for sale: the models are made in research laboratories from pluripotent stem cell lines, and none is offered clinically or reproductively."reversibility: "context"issues: ["The 2023 human integrated embryo model reports are described without citations.", "The 2016 thirteen-day human embryo culture result needs a citation."]issues: ["The 2023 human integrated embryo model reports are described without citations.", "The 2016 thirteen-day human embryo culture result needs a citation."]------ lines 28–82 → 29–8311 unchanged lines not shown
}}`````` **Stem-cell-based embryo models** are structures assembled from cultured stem cells that reproduce features of early embryonic development without an egg, a sperm, or fertilisation. They are widely called synthetic embryos, a term nearly every researcher in the field objects to. None has produced a live animal in any species, and the most advanced human versions self-organise for a period roughly equivalent to the first two weeks of development before deteriorating. Their significance is that they fall outside the legal definition of an embryo almost everywhere, while resembling one closely enough that the exemption has become difficult to defend.**Stem-cell-based embryo models** are structures assembled from cultured stem cells that reproduce features of early embryonic development without an egg, a sperm, or fertilisation. They are widely called synthetic embryos, a term nearly every researcher in the field objects to. None has produced a live animal in any species, and the most advanced human versions self-organise for a period roughly equivalent to the first two weeks of development before deteriorating. They matter because they fall outside the legal definition of an embryo almost everywhere while resembling one closely enough that the exemption has become difficult to defend. ## What they are## What they are All of them start from pluripotent cells: embryonic stem cell lines, or [[induced-pluripotent-stem-cells]] made by [[yamanaka-factors|factor-based reprogramming]] of adult tissue. The models divide by which parts of the conceptus they include.Every model starts from pluripotent cells: embryonic stem cell lines, or [[induced-pluripotent-stem-cells]] made by [[yamanaka-factors|factor-based reprogramming]] of adult tissue. The models are classified by which parts of the conceptus they include. - **Blastoids** model the blastocyst. Mouse versions were made in 2018 by combining embryonic and trophoblast stem cells; human blastoids followed in 2021 from two directions, one starting from naive pluripotent cells and one arising during the reprogramming of fibroblasts.[^rivron2018][^yu2021] They form an outer trophectoderm-like layer, an inner cell mass–like cluster, and a cavity, and some attach to cultured endometrial cells in a way that resembles the first step of implantation.- **Blastoids** model the blastocyst. Mouse versions were made in 2018 by combining embryonic and trophoblast stem cells; human blastoids followed in 2021 from two directions, one starting from naive pluripotent cells and one arising during the reprogramming of fibroblasts.[^rivron2018][^yu2021] They form an outer trophectoderm-like layer, a cluster resembling the inner cell mass, and a cavity, and some attach to cultured endometrial cells in a way that resembles the first step of implantation.- **Gastruloids** model the body plan without extraembryonic tissue. Aggregates of pluripotent cells, given a pulse of Wnt signalling, break symmetry, establish an anterior–posterior axis, and express the segmentation gene programme in the correct order. They have no yolk sac, no placenta, and no head, and are not blastocyst-derived, so they cannot be confused with an embryo at any stage.- **Gastruloids** model the body plan without extraembryonic tissue. Aggregates of pluripotent cells, given a pulse of Wnt signalling, break symmetry, establish an anterior-posterior axis, and express the segmentation gene programme in the correct order. They have no yolk sac, no placenta and no head, and they do not derive from a blastocyst, so they cannot be confused with an embryo at any stage.- **Integrated post-implantation models** are the contentious category. Mouse versions reported in 2022 by two groups combined embryonic stem cells with cells pushed toward trophoblast and primitive endoderm fates, and produced structures with a beating heart tube, a neural tube, somites, a gut, and a yolk sac.[^tarazi2022] Human counterparts reported in 2023 recapitulated aspects of the amniotic cavity, yolk sac, and bilaminar disc to about the fourteenth day of development.- **Integrated post-implantation models** are the contentious category. Mouse versions reported in 2022 by two groups combined embryonic stem cells with cells pushed toward trophoblast and primitive endoderm fates, and produced structures with a beating heart tube, a neural tube, somites, a gut, and a yolk sac.[^tarazi2022] Human counterparts reported in 2023 recapitulated aspects of the amniotic cavity, yolk sac, and bilaminar disc to about the fourteenth day of development. Efficiency is low throughout. Typically a small percentage of aggregates form structures with correct morphology, the rest producing disorganised tissue, which is itself a reason to doubt that the successful ones are following the same developmental logic as an embryo rather than arriving at a similar appearance by another route.Efficiency is low throughout. Typically a small percentage of aggregates form structures with correct morphology and the rest produce disorganised tissue. That low yield is itself a reason to doubt that the successful ones follow the same developmental logic as an embryo; they may be arriving at a similar appearance by another route. > [!note] Terminology> [!note] Terminology> "Synthetic" is doubly misleading: nothing is chemically synthesised, and the cells are ordinary human or mouse cells. "Embryo model" is the term used by the International Society for Stem Cell Research and in the UK code of practice. Popular coverage in 2022 and 2023 that described mouse models as embryos "created without eggs or sperm" prompted public corrections from several of the researchers involved.> "Synthetic" is doubly misleading: nothing is chemically synthesised, and the cells are ordinary human or mouse cells. "Embryo model" is the term used by the International Society for Stem Cell Research and in the UK code of practice. Popular coverage in 2022 and 2023 that described mouse models as embryos "created without eggs or sperm" prompted public corrections from several of the researchers involved. ## Why the field wants them## Why the field wants them The period between implantation and the fourth week of human gestation is the least understood phase of human development, for a straightforward reason: it happens inside a uterus, is inaccessible, and is when a large share of pregnancies fail. Donated IVF embryos are scarce, ethically constrained, and cannot legally be cultured past fourteen days in most jurisdictions.The period between implantation and the fourth week of gestation is the least understood phase of human development. It happens inside a uterus, where it cannot be observed, and it is when a large share of pregnancies fail. Donated IVF embryos are scarce, ethically constrained, and cannot legally be cultured past fourteen days in most jurisdictions. Embryo models supply an alternative that is renewable, genetically tractable, and produced in quantity. Concrete applications include studying the causes of early miscarriage, which rise steeply with maternal age for reasons examined in [[reproductive-longevity]]; mapping the signalling that specifies the body axes; testing whether a drug or environmental exposure is teratogenic at a stage no other model reaches; and examining the origin of congenital anomalies. They also intersect with [[embryo-selection]], since much of what a clinic infers from an embryo's morphology rests on developmental assumptions that models can now test directly.Embryo models offer an alternative that is renewable, genetically tractable and available in quantity. Concrete applications include studying the causes of early miscarriage, which rise steeply with maternal age for reasons examined in [[reproductive-longevity]]; mapping the signalling that specifies the body axes; testing whether a drug or environmental exposure is teratogenic at a stage no other model reaches; and examining the origin of congenital anomalies. They also intersect with [[embryo-selection]], since much of what a clinic infers from an embryo's morphology rests on developmental assumptions that models can now test directly. The models are close cousins of [[organoids]], which self-organise from stem cells into tissue-like structures, and share both their strengths and their ceiling: real spatial organisation, real gene expression programmes, no vasculature, and limited maturity.The models are close relatives of [[organoids]], which self-organise from stem cells into tissue-like structures. They share the strengths of organoids (real spatial organisation and real gene expression programmes) and their limits: no vasculature and limited maturity. ## The fourteen-day rule and its erosion## The fourteen-day rule and its erosion The fourteen-day limit on culturing human embryos originates in the 1984 Warnock report in the United Kingdom and was written into the Human Fertilisation and Embryology Act 1990.[^warnock1984] It was chosen because the primitive streak appears around day fourteen, after which twinning is no longer possible and individuation can be said to have begun. It was also chosen because at the time nobody could culture an embryo anywhere near that long, which made it a rule that cost nothing. The rule has since been adopted, formally or in practice, in most countries that fund human embryo research, and it is one of the few pieces of bioethical line-drawing that survived four decades intact.The fourteen-day limit on culturing human embryos originates in the 1984 Warnock report in the United Kingdom and was written into the Human Fertilisation and Embryology Act 1990.[^warnock1984] It was chosen because the primitive streak appears around day fourteen, after which twinning is no longer possible and individuation can be said to have begun. A further reason was that nobody at the time could culture an embryo anywhere near that long, so the rule cost researchers nothing. It has since been adopted, formally or in practice, in most countries that fund human embryo research, and it is one of the few bioethical lines that survived four decades intact. Two developments undermined it. Human embryos were cultured to around thirteen days in 2016, making the limit binding for the first time. And embryo models arrived, which are not embryos under the statutory definitions and are therefore not covered by the limit at all. The UK Act defines an embryo as a live human embryo "where fertilisation is complete"; a structure that was never fertilised does not qualify.Two developments undermined it. In 2016 human embryos were cultured to around thirteen days, which made the limit binding for the first time. Then embryo models arrived; they are not embryos under the statutory definitions and so the limit does not cover them at all. The UK Act defines an embryo as a live human embryo "where fertilisation is complete"; a structure that was never fertilised does not qualify. The International Society for Stem Cell Research revised its guidelines in 2021, moving culture beyond fourteen days from a prohibited category into one requiring case-by-case specialised review and public consultation, and placing integrated embryo models under oversight while leaving non-integrated models such as gastruloids largely unrestricted.[^isscr2021] In 2024 a UK-based group published a voluntary code of practice for stem-cell-based embryo models with an independent oversight committee, an instance of the self-governance approach whose founding precedent is the [[asilomar-conference]] and whose weakness is the same: it binds only those who agree to be bound. Whether a research community should be able to relax a limit it originally proposed is the recurring objection, and it is the point at which arguments from the [[precautionary-principle]] enter the debate.The International Society for Stem Cell Research revised its guidelines in 2021, moving culture beyond fourteen days from a prohibited category into one requiring case-by-case specialised review and public consultation, and placing integrated embryo models under oversight while leaving non-integrated models such as gastruloids largely unrestricted.[^isscr2021] In 2024 a UK-based group published a voluntary code of practice for stem-cell-based embryo models with an independent oversight committee, This is the self-governance approach whose founding precedent is the [[asilomar-conference]], and it has the same weakness: it binds only those who agree to be bound. The recurring objection is that a research community should not be the one to relax a limit it originally proposed, and that objection is where arguments from the [[precautionary-principle]] enter the debate. > [!debate] What would make a model an embryo> [!debate] What would make a model an embryo> Proposals for a bright line fall into three families. A *provenance* test asks whether fertilisation occurred, which is clear but arbitrary. A *morphological* test asks whether the structure has the parts of an embryo, which is vague. A *potentiality* test asks whether it could develop into a person if transferred, which is the criterion most philosophers regard as morally relevant and the hardest to apply, since testing it directly requires the transfer nobody permits.> Proposals for a bright line fall into three families. A *provenance* test asks whether fertilisation occurred, which is clear but arbitrary. A *morphological* test asks whether the structure has the parts of an embryo, which is vague. A *potentiality* test asks whether it could develop into a person if transferred. Most philosophers regard potentiality as the morally relevant criterion, but it is the hardest to apply, since testing it directly requires the transfer nobody permits. ## Limitations## Limitations No embryo model has produced a live animal. Mouse models transferred to a uterus have implanted in some experiments and then failed. Whether this reflects a fixable technical deficit or a categorical difference between a model and an embryo is unresolved, and it is the single most consequential open question in the field, because a model that could develop to term would collapse the regulatory distinction entirely.No embryo model has produced a live animal. Mouse models transferred to a uterus have implanted in some experiments and then failed. It is unresolved whether this reflects a fixable technical deficit or a categorical difference between a model and an embryo. That is the most consequential open question in the field, because a model that could develop to term would collapse the regulatory distinction entirely. Fidelity is uneven. Single-cell transcriptomic comparisons with real primate and human embryos show that some cell types in models match their in vivo counterparts closely and others do not, with extraembryonic lineages generally poorer matches than embryonic ones. Timing is often wrong, and models frequently produce cells in the wrong proportions. The structures also lack a maternal interface, so nothing about implantation biology that depends on the endometrium can be modelled properly, which is a limitation shared with attempts at [[ectogenesis]] and every version of the [[artificial-womb]].Fidelity is uneven. Single-cell transcriptomic comparisons with real primate and human embryos show that some cell types in models match their in vivo counterparts closely and others do not, with extraembryonic lineages generally poorer matches than embryonic ones. Timing is often wrong, and models frequently produce cells in the wrong proportions. The structures also lack a maternal interface, so no part of implantation biology that depends on the endometrium can be modelled properly. Attempts at [[ectogenesis]] and every version of the [[artificial-womb]] share that limitation. ## Ethics and governance## Ethics and governance The moral-status question is unavoidable and unsettled. If moral status attaches to a developmental potential rather than to an origin, then a model that grows better will at some point acquire whatever status an embryo has, and the field will have arrived there gradually and without a decision. If status attaches to fertilisation, models never acquire it however lifelike they become. Neither position is fringe, and the disagreement is not empirical.The moral-status question is unavoidable and unsettled. If moral status attaches to a developmental potential rather than to an origin, then a model that grows better will at some point acquire whatever status an embryo has, and the field will have arrived there gradually and without a decision. If status attaches to fertilisation, models never acquire it however lifelike they become. Neither position is fringe, and no experiment could settle the disagreement between them. Downstream concerns are more tractable. Consent from the donors of the original stem cell lines rarely mentioned embryo models, since the lines predate them. Public trust is affected by terminology, and the field has been damaged by coverage it did not write; the reception of [[human-cloning]] in the late 1990s is the standing example of how a research programme can be defined by a word it did not choose. Transfer to a human or animal uterus is prohibited under every existing guideline, and the enforcement question resembles the one described in [[governance-of-genome-editing]]: rules that bind funded academic laboratories in a handful of countries do not bind a well-resourced private effort elsewhere.Downstream concerns are more tractable. Consent from the donors of the original stem cell lines rarely mentioned embryo models, since the lines predate them. Terminology affects public trust, and the field has been damaged by coverage it did not write. The reception of [[human-cloning]] in the late 1990s is the standing example of a research programme defined by a word it did not choose. Transfer to a human or animal uterus is prohibited under every existing guideline, and the enforcement question resembles the one described in [[governance-of-genome-editing]]: rules that bind funded academic laboratories in a handful of countries do not bind a well-resourced private effort elsewhere. A further prospect complicates the picture. If [[in-vitro-gametogenesis]] succeeds, gametes could be made from stem cells and used to create real embryos, at which point the interesting entity is unambiguously an embryo and the model debate becomes moot for reproductive purposes. Some researchers have suggested models could instead be a source of tissue, connecting them to [[lab-grown-organs]] and interspecies chimera work, though nothing at the current level of organisation supports that.A further prospect complicates the picture. If [[in-vitro-gametogenesis]] succeeds, gametes could be made from stem cells and used to create real embryos. The entity of interest would then be unambiguously an embryo, and the model debate would become moot for reproductive purposes. Some researchers have suggested models could instead be a source of tissue, connecting them to [[lab-grown-organs]] and interspecies chimera work, though nothing at the current level of organisation supports that. The near-term question is narrower than the philosophy suggests: whether funders and journals will require embryo-model work to pass through review bodies designed for embryo research, and whether a voluntary code with no statutory backing survives contact with a laboratory that decides not to participate.The near-term questions are narrower than the philosophy suggests. One is whether funders and journals will require embryo-model work to pass through review bodies designed for embryo research. The other is whether a voluntary code with no statutory backing holds up once a laboratory decides not to participate. ## See also## See also removed, struck through added, underlinedLine numbers count the serialised markdown of each revision, frontmatter included.
81 lines are the same in both revisions, and 36 of them are not shown. Neither revision here is necessarily the current article — read Stem-cell-based embryo models for the text this wiki stands behind today.